4th Asia-Pacific Conference Preliminary Program - Tuesday, 7 September 2010
 
Join ISPOR  | Sign up for mailing List  | Follow Us: LinkedIn Twitter Facebook YouTube
Tuesday, 7 September 2010
Sunday, 5 September >> Monday, 6 September >> Tuesday, 7 September
7:00AM 8:15AM
ISPOR ASIA CONSORTIUM MEETING (BY INVITATION)
Education Committee Business Meeting
7:30AM 8:30AM
EDUCATIONAL SYMPOSIUM (Sponsored by Novartis)
Estimating the Humanistic and Cost Burden of Chronic Obstructive Pulmonary Disease (COPD)
8:45AM 9:00AM
WELCOME
 Surachat Ngorsuraches PhD, RPh Surachat Ngorsuraches PhD, RPh, Program Committee Co-Chair, and Associate Professor, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Songkhla, Thailand
PRESENTATION OF ISPOR DISTINGUISHED SERVICE AWARDS
Scott D. Ramsey MD, PhD Presented by: Scott D. Ramsey MD, PhD, 2010-2011 ISPOR President,  Member, Fred Hutchinson Cancer Research Center, and Professor, Department of Medicine, University of Washington, Seattle, WA, USA
Awardees:
 Surachat Ngorsuraches PhD, RPh Surachat Ngorsuraches PhD, RPh, Program Committee Co-Chair, and Associate Professor, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Songkhla, Thailand
Vithaya Kulsomboon PhD Vithaya Kulsomboon PhD, Program Committee Co-Chair, Associate Professor and Associate Dean for Planning and Development, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand
Gordon G. Liu PhD Gordon G. Liu PhD, 2004-2006 Chair, ISPOR Asia Consortium Executive Committee, Professor of Economics, and Executive Director, The Health Economics and Management Institute, Guanghua School of Management, Peking University, Beijing, China
Kenneth KC Lee JP, MPhil, PhD Kenneth KC Lee JP, MPhil, PhD, Professor of Pharmacy and Head of Pharmacy Program, School of Medicine and Health Sciences, Monash University, Kuala Lumpur, Malaysia
Shanlian Hu MD, MSc Shanlian Hu MD, MSc, 2008-2010 Chair, ISPOR Asia Consortium Executive Committee, Professor, School of Public Health, Fudan University, and Director, Center for Health Development Research, Shanghai Bureau of Health, Shanghai, China
9:00AM 10:30AM
THIRD PLENARY SESSION
HEALTH CARE DATA IN ASIA: COLLECTING, SHARING, AND USING

Real world health care data presents a significant opportunity for health economists and outcomes researchers to conduct research that supports health technology assessment and health poli­cymaking. The availability, transparency and proper use of data would encourage decision-making based on real world evidence. In this session, speakers from Taiwan, South Korea, China Mainland, Thailand, Malaysia and Japan will present what and how data is collected, shared and used, and what mechanism can be adopted to improve data quality.

Moderator:
Moderator: Surachat Ngorsuraches PhD, RPh Surachat Ngorsuraches PhD, RPh, Associate Professor, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Songkhla, Thailand
Panelists:
Samrit Srithamrongsawat PhD Samrit Srithamrongsawat PhD, Director, Health Insurance System Research Office, Nontaburi, Thailand
Raoh-Fang Pwu PhD Raoh-Fang Pwu PhD, Acting Director, Division of Health Technology Assessment, Center for Drug Evaluation, Taipei, Taiwan
Ling Xu PhD Ling Xu PhD,  Director,Center for Health Statistics and Information, Ministry of Health, Beijing, China
SeungJin Bae PhD SeungJin Bae PhD, Senior Researcher, Health Insurance Review and Assessment Service, Seoul, Seoul, Korea
Shunya Ikeda MD, MS, DMSc Shunya Ikeda MD, MS, DMSc, Professor of Public Health and Pharmacoeconomics, School of Pharmacy, International University of Health and Welfare, Tochigi, Japan
Syed Mohamed Aljunid MD, MSc, PhD, FAMM Syed Mohamed Aljunid MD, MSc, PhD, FAMM, Professor of Health Economics, and Consultant of Public Health Medicine, Senior Research Fellow, United Nations University-International Institute of Global Health National University of Malaysia, Kuala Lumpur, Malaysia
Respondents:
Ashoke Bhattacharjya PhD Ashoke Bhattacharjya PhD, Executive Director, Global Economic Affairs, Johnson & Johnson, New Brunswick, NJ, USA
Bruce Crawford MA, MPH Bruce Crawford MA, MPH, General Manager, Asia, Mapi Values, Tokyo, Japan
Jennifer Sung PharmD, MS Jennifer Sung PharmD, MS, Executive Director, Global Health Economics & Outcomes Research, Novartis, Shanghai, China
10:30AM 11:00AM
BREAK, EXHIBITS, & RESEARCH POSTER PRESENTATIONS VIEWING
11:00AM 12:00PM
ISSUE PANELS & WORKSHOPS SESSION II

IP3: HOW HIGH IS HIGH OF COST-EFFECTIVENESS THRESHOLD IN ASIA: VALUE JUDGMENT OF QALYS OR HOW MUCH WE CAN SPEND

Moderator: Mingliang Zhang PhD, Senior Director, Worldwide Market Access, Global Strategic Marketing and Market Access, Johnson and Johnson Pharmaceutical Services, Raritan, NJ, USA
Panelists: Nara Decharin PhD, Manager, AstraZeneca Thailand, Bangkok, Thailand; Yen-Huei (Tony) Tarn PhD, MS, Executive Director, Center for Pharmaceutical Care Development, National Union of Pharmacist Association, Taipei, Taiwan; Su-Kyoung Ko PhD, Director, Head of Market Access, Market Access Division, Pfizer Korea, Seoul, South Korea

 

IP4: RISK-SHARING SCHEMES IN THE ASIAN MARKETPLACE: WHAT ARE THE STEPS FOR SUCCESS?

Moderator: Lisbet Coulton, Director, International Pricing and Reimbursement, United BioSource Corporation - Europe, London, UK
Panelists: Abdulkadir Keskinaslan MD, MBA, MPH, Market Pricing Director Asia, Novartis Pharma AG, Basel, Switzerland; Nathorn Chaiyakunapruk PharmD, PhD, Associate Professor, Center of Pharmaceutical Outcome Research, Department of Pharmacy Practice, Naresuan University, Muang, Phitsanulok, Thailand; Wen Chen PhD, Professor, Center for Pharmacoeconomic Research and Evaluation, Fudan University, Shanghai, China

 

W4: CHALLENGES IN ADAPTING NORTH AMERICAN & EUROPEAN PHARMACOECONOMIC RESEARCH TO THE ASIA PACIFIC SETTING

Discussion Leaders: David Thompson PhD, Senior Vice President, Health Economics & Strategic Consulting, i3 Innovus, Medford, MA, USA; George Papadopoulos BSc, President, Emerald CG, McMahon's Point, NSW, Australia

 

W5: VALUE-BASED PRICING AND REIMBURSEMENT IN JAPAN: CURRENT METHODS AND FUTURE POTENTIALS

Discussion Leaders: Isao Kamae MD, DrPH, Professor of Pharmacoeconomics, JPMA Research and Education Project, Graduate School of Health Management, Keio University, Fujisawa-City, Kanagawa, Japan; Makoto Kobayashi ME, Director, CRECON Research & Consulting Inc, Tokyo, Japan; Naohiro Nakahara BSc, Research Scientist, Health Outcomes Research, Medical Science, Eli Lilly Japan K.K., Kobe, Japan

 

W6: ASSESSMENT OF USE OF PHARMACOECONOMICS AND OUTCOMES RESEARCH IN ASIA: THE ISPOR ASIA CONSORTIUM NEEDS SURVEY REPORT

Discussion Leaders: Jeff J. Guo PhD, RPh, Associate Professor of Pharmacoeconomics & Pharmacoepidemiology, University of Cincinnati Medical Center, Cincinnati, OH, USA; Shu Chuen Li PhD, MBA, MSc, BSc, Professor, Chair & Head, University of Newcastle, School of Biomedical Sciences, Callaghan, NSW, Australia; Shanlian Hu MD, MSc, Professor, School of Public Health, Fudan University, and Director, Center for Health Development Research, Shanghai Bureau of Health, Shanghai, China; Kenneth KC Lee PhD, Professor, School of Pharmacy, The Chinese University of Hong Kong, Hong Kong, China

12:00PM 1:30PM
LUNCH, EXHIBITS, & RESEARCH POSTER PRESENTATIONS VIEWING
12:15PM 1:15PM
EDUCATIONAL SYMPOSIUM (Sponsored by Johnson & Johnson Pharmaceutical Services)
Market Access to Biologics in Asia-Pacific
1:30PM 2:30PM
ISSUE PANELS & WORKSHOPS SESSION III

IP5: STRENGTHENING HEALTH TECHNOLOGY ASSESSMENT CAPACITY IN DEVELOPING COUNTRIES: CONTRIBUTIONS OF INTERNATIONAL ORGANIZATIONS

Moderator: Yot Teerawattananon MD, PhD, Program Leader, Health Intervention and Technology Assessment Program (HITAP), Nonthaburi, Thailand
Panelists: Scott Ramsey PhD, MD, Member & Professor, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA; Laura Sampietro-Colom MD, PhD, President, Health Technology Assessment International (HTAi), Edmonton, AB, Canada; Kalipso Chalkidou PhD, MD, Director - NICE International, National Institute for Health and Clinical Excellence, London, UK
(Speakers at this panel are invited)

Y. Teerawattananon S. Ramsey L. Sampietro-Colom K. Chalkidou
 

W7: Conducting Outcomes Research in Asia: Challenges of Local Adaptation of Global Outcomes Research Studies

Discussion Leaders: Bruce Crawford MA, MPH, General Manager, Asia, Mapi Values, Tokyo, Japan; Lillian YJ Wang MA, Senior Market Access Manager, Novartis (Taiwan) Co., Ltd., Taipei, Taiwan; Jittrakul Leartsakulpanitch PhD, Outcomes Research Associate, Pfizer (Thailand) Limited, Bangkok, Thailand

 

W8: THE NEW GERMAN METHODS FOR ECONOMIC EVALUATION AND THEIR APPLICABILITY IN ASIA

Discussion Leaders: J. Jaime Caro MD, Senior Vice President of Health Economics, United BioSource Corporation, Lexington, MA, USA; Charalabos-Markos Dintsios MPH, MA, Scientific Staff Department of Health Economics, Institute for Quality and Efficiency in Health Care (IQWiG), Cologne, Germany; Anja Schwalm MSc, Health Economist, Health Economics, Institute for Quality and Efficiency in Health Care (IQWiG), Cologne, Germany; Isao Kamae MD, DrPH, Professor of Pharmacoeconomics, JPMA Research and Education Project, Graduate School of Health Management, Keio University, Fujisawa-City, Kanagawa, Japan

 

W9: USING HEALTH ECONOMICS AND OUTCOMES RESEARCH TO INFORM HEALTH POLICY IN NEW ZEALAND

Discussion Leaders: Sarah Norris BSc, MPhil, PhD, Director, Health Technology Analysts Pty Ltd, Sydney, NSW, Australia; Ray Kirk PhD, MSc, BSc, Associate Professor, Health Sciences Centre, Christchurch, New Zealand; Paul Scuffham PhD, Professor of Health Economics, Griffith University, Meadowbrook, Australia

 

HEALTH CARE DECISION-MAKER’S CASE STUDIES: A PANEL DISCUSSION

Moderators: Shanlian Hu MD, MSc, Professor, School of Public Health, Fudan University, and Director, Center for Health Development Research, Shanghai Bureau of Health, Shanghai, China; Syed Mohamed Aljunid MD, MSc, PhD, FAMM

Professor of Health Economics and Senior Research Fellow, United Nations University-International Institute of Global Health (UNU-IIGH), National University of Malaysia, Kuala Lumpur, Malaysia

Panelists: Vithaya Kulsomboon PhD, Associate Dean/Associate Professor, Department of Social and Administrative Pharmacy, Chulalongkorn University, Patumwan, Payathai, Bangkok, Thailand; Hsiang-Wen Lin PhD, Assistant Professor, School of Pharmacy and Graduate Institute, China Medical University, Taichung, Taiwan; Mohammadreza Amiresmaili PhD, Assistant Professor, Health Management, Kerman Medical University, Kerman, Iran; Sirada Maphanta PharmD, MS, Director, Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Naresuan University, Muang, Phitsanulok, Thailand

2:30PM 2:45PM
BREAK, EXHIBITS, & RESEARCH POSTER PRESENTATIONS VIEWING
2:45PM 3:45PM
ISSUE PANELS & WORKSHOPS SESSION IV

IP6: DESIGNING CLINICAL TRIALS: THE CHALLENGES OF MEETING THE NEEDS OF PAYERS VS REGULATORS

Moderator: William Montgomery RPh, Senior Research Scientist, Eli Lilly and Company, West Ryde, NSW, Australia
Panelists: Rosalie Viney PhD, Associate Professsor, Centre for Health Economics Research and Evaluation, University of Technology, Sydney, Broadway, NSW, Australia; Michael Drummond PhD, Professor of Health Economics, Centre for Health Economics, University of York, York, UK; Ruth Lopert BSc, BMed, BMedSci, Principal Medical Adviser, Therapeutic Goods Administration, Canberra, Australia

 

IP7: APPLICATION OF ECONOMIC EVALUATION TOOLS FROM THE UNITED STATES AND EUROPE TOWARD PRICING AND REIMBURSEMENT STRATEGIES IN THE ASIA-PACIFIC REGION

Moderator: Diana Brixner RPh, PhD, Professor and Chair, Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT, USA
Panelists: Gordon G. Liu PhD, Professor of Economics, Executive Director, The Health Economics and Management Institute, Guanghua School of Management, Peking University, Beijing, China; Abdulkadir Keskinaslan MD, MBA, MPH, Market Pricing Director Asia, Novartis Pharma AG, Basel, Switzerland; Alan Haycox BA, MA, PhD, Reader in Health Economics, University of Liverpool, Liverpool, UK

 

W10: SELECTING THE OPTIMAL TARGET POPULATION FOR FORMULARY COVERAGE

Discussion Leaders: Eric Q Wu PhD, Vice President, Analysis Group, Inc., Boston, MA, USA; Dezhi Yu PhD, Director, China Ministry of Health, Beijing, Beijing, China; Jipan Xie MD, PhD, Associate, Analysis Group, Inc., Boston, MA, USA; Ruimin Gu PhD, College of Pharmacy, Nankai University, Tianjin, China

 

W11: SHARING EXPERIENCES OF USING CASEMIX SYSTEMS IN THAILAND

Discussion Leaders: Supasit Pannarunothai MD, PhD, Professor, Community Family and Occupational Medicine, Naresuan University, Muang, Phitsanulok, Thailand; Boonchai Kijsanayotin MD, PhD, Director, Bureau of Policy and Strategy, Ministry of Public Health, Muang, Nonthaburi, Thailand; Nilawan Upakdee PhD, Director, Naresuan University, Muang, Phitsanulok, Thailand; Orathai Khiaocharoen MEd, Phitsanulok Provincial Health Office, Muang, Phitsanulok, Thailand

 

W12: USING POPULATION-BASED DATA IN OUTCOMES RESEARCH STUDIES: STRENGTHS, WEAKNESSES AND LESSONS LEARNED

Discussion Leaders: Wen Chen PhD, Professor, Center for Pharmacoeconomic Research and Evaluation, Fudan University, Shanghai, China; Chao-Hsiun Tang PhD, Professor, School of Health Care Administration, Taipei Medical University, Taipei, Taiwan; Bruce Crawford MA, MPH, General Manager, Asia, Mapi Values, Tokyo, Japan; Jennifer Sung MS, PharmD, Executive Director, Health Economics & Outcomes Research, Global Health Economics & Outcomes Research, Novartis Pharmaceuticals Corporation, Shanghai, China

3:45PM 4:00PM
BREAK, EXHIBITS, & RESEARCH POSTER PRESENTATIONS VIEWING
4:00PM 5:00PM
ISSUE PANELS & WORKSHOPS SESSION V

IP8: MANAGING COSTS AND QUALITY OF CARE IN OLDER ADULTS – A TALE OF 3 COUNTRIES

Moderator: Vithaya Kulsomboon PhD, Associate Dean/Associate Professor, Department of Social and Administrative Pharmacy, Chulalongkorn University, Bangkok, Thailand
Panelists: Sang-Eun Choi MPh, PhD, Professor, College of Pharmacy, Seoul National University, Seoul, South Korea; Gary Oderda PharmD, MPH, Professor, Department of Pharmacotherapy, University of Utah, Salt Lake City, UT, USA; Netnapis Suchonwanich MS, Pharm, Assistant Secretary General, National Health Security Office, Bangkok, Thailand

 

IP9: PHARMACEUTICAL REIMBURSEMENT – TO RESTRICT OR NOT TO RESTRICT: LESSONS LEARNT FROM AUSTRALIAN EXPERIENCE

Moderator: Adele Weston PhD, Director, Health Technology Analysts Pty Ltd, Balmain NSW, Australia
Panelists: Paul Scuffham PhD, Professor of Health Economics, Griffith University, Meadowbrook, Australia; Rosalie Viney PhD, Associate Professor, Centre for Health Economics Research and Evaluation, University of Technology, Sydney, Broadway, NSW, Australia; Cammy Yuen, Director Market Access, Abbott Australia, Sydney, Australia

 

W14: METHODOLOGICAL ISSUES ON USING THE EQ-5D INDEX IN OUTCOMES RESEARCH

Discussion Leaders: Alex Z. Fu PhD, Assistant Professor, Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA; Nan Luo PhD, Assistant Professor, Department of Epidemiology and Public Health & Centre for Health Services Research, National University of Singapore, Singapore

 

DRUG REIMBURSEMENT POLICY AND OUTCOMES RESEARCH IN KOREA

Discussion Leaders: Eui-Kyung Lee PhD, ISPOR Korea Chapter President & Professor, Graduate School of Clinical Pharmacy, Sookmyung Women’s University, Seoul, South Korea; Jeonghoon Ahn PhD, MA, ISPOR Korea Chapter Secretary and Senior Director, National Evidence-based Healthcare Collaborating Agency (NECA), Seoul, South Korea; Sukyoung Ko PhD Korea Chapter member and Director, Department of Market Access, Pfizer Korea, Seoul, South Korea

5:15PM 6:00PM
ISPOR RESEARCH AWARDS PRESENTATION
ISPOR 5TH ASIA-PACIFIC CONFERENCE ANNOUNCEMENT
CLOSING REMARKS
 
Bong-Min Yang PhD Moderated by: Bong-Min Yang PhD, 2010-2012 Chair, ISPOR Asia Consortium Executive Committee, and Professor of Economics, School of Public Health, Seoul National University, Seoul, South Korea

ISPOR RESEARCH AWARDS PRESENTATION Surachat Ngorsuraches PhD, RPh, Conference Co-chair, and Associate Professor, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Songkhla, Thailand

Vithaya Kulsomboon PhD, Conference Co-chair, Associate Professor and Associate Dean for Planning and Development, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand

ISPOR 5TH ASIA-PACIFIC CONFERENCE ANNOUNCEMENT
Tony Yen-Huei Tarn MS, PhD, ISPOR 5th Asia-Pacific Conference Chair, and Executive Director, Center for Pharmaceutical Care Development, National Union of Pharmacist Association, Taipei, Taiwan

CLOSING REMARKSSurachat Ngorsuraches PhD, RPh, Conference Co-chair, and Associate Professor, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Songkhla, Thailand

Vithaya Kulsomboon PhD, Conference Co-chair, Associate Professor and Associate Dean for Planning and Development, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand

  Sunday, 5 September >> Monday, 6 September >> Tuesday, 7 September

 

Contact ISPOR @ info@ispor.org  |  View Legal Disclaimer
©2014 International Society for Pharmacoeconomics and Outcomes Research. All rights reserved under International and Pan-American Copyright Conventions. 
Website design by Eagle Systems USA, Inc.